New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
08:51 EDTJAZZJazz Pharmaceuticals price target raised to $70 from $63 at WallachBeth
WallachBeth raised its price target for Jazz Pharmaceuticals following the company's better than expected Q4 results and reiterates a Buy rating on the stock. The firm believes Jazz's outlook leaves room for upside.
News For JAZZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 24, 2014
08:15 EDTJAZZJazz Pharmaceuticals price target raised to $201 from $163 at Canaccord
Subscribe for More Information
October 17, 2014
07:53 EDTJAZZJazz Pharmaceuticals shares 'signifincantly undervalued,' says FBR Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use